Citadel Advisors - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$310,634
-34.1%
215,718
+13.9%
0.00%
Q2 2023$471,626
+0.1%
189,408
+7.7%
0.00%
Q1 2023$471,313
-76.3%
175,863
-52.0%
0.00%
Q4 2022$1,990,762
+11.6%
366,623
+156.8%
0.00%
Q3 2022$1,784,000
+5.4%
142,788
-58.3%
0.00%
Q2 2022$1,692,000
-32.9%
342,694
+3.3%
0.00%
Q1 2022$2,522,000
-26.0%
331,736
-0.6%
0.00%
-100.0%
Q4 2021$3,408,000
+199.2%
333,805
+293.0%
0.00%
Q3 2021$1,139,000
-64.8%
84,934
-42.5%
0.00%
Q2 2021$3,239,000
-25.7%
147,622
-18.6%
0.00%
Q1 2021$4,362,000
-28.1%
181,276
-46.2%
0.00%
-100.0%
Q4 2020$6,064,000
+46.8%
337,080
-5.8%
0.00%0.0%
Q3 2020$4,131,000
+112.6%
357,664
+346.6%
0.00%0.0%
Q2 2020$1,943,000
+40.7%
80,091
-36.1%
0.00%0.0%
Q1 2020$1,381,000
-59.6%
125,269
-3.2%
0.00%0.0%
Q4 2019$3,419,000
+754.8%
129,376
+638.3%
0.00%
Q3 2019$400,000
-43.5%
17,524
-24.1%
0.00%
Q2 2019$708,000
-84.7%
23,096
-91.7%
0.00%
-100.0%
Q1 2019$4,623,000
+40.5%
278,508
+62.1%
0.00%0.0%
Q4 2018$3,291,000
+1254.3%
171,855
+3599.8%
0.00%
Q3 2018$243,000
-21.1%
4,645
-44.2%
0.00%
Q1 2018$308,0008,3240.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders